Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/23/2005US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity
08/23/2005CA2469592C Hiv integrase inhibitors
08/23/2005CA2370888C Renin inhibitors
08/23/2005CA2310585C Novel administration form comprising an acid-labile active compound
08/23/2005CA2266884C Inhibition of 26s and 20s proteasome by indanones
08/23/2005CA2265668C Methylphenidate tablet
08/23/2005CA2232356C Method of producing multi-layer medicaments in solid form for oral or rectal administration
08/23/2005CA2223469C Use of dopamine receptor antagonists in palliative tumour therapy
08/23/2005CA2218714C Dosage form comprising oxybutynin
08/23/2005CA2186044C Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
08/23/2005CA2185883C The use of dimeticone as a transport and carrier system and/or drug delivery system
08/23/2005CA2176360C Pharmaceutical emulsion
08/23/2005CA2172402C Volatile active substance containing plaster that may be produced without solvents
08/23/2005CA2162761C Antineoplastic cyclolignan derivatives
08/23/2005CA2153235C Compounds having selectivity for retinoid x receptors
08/23/2005CA2147341C Skin treatment composition comprising l-lactic acid and n-acetyl-l-cysteine
08/23/2005CA2137668C Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
08/23/2005CA2119782C Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
08/23/2005CA2111571C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
08/23/2005CA2109161C Substituted 1-h-3-aryl-pyrrolidine-2,4-dione derivatives
08/23/2005CA2089442C Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them
08/23/2005CA2064373C Piperidine derivatives
08/19/2005CA2458026A1 Antifungal and/or antimycotic external preparation for nail
08/18/2005WO2005076011A2 Use of glut1 transporter expressed in blood brain barrier cells for screening for pharmacologically active substances
08/18/2005WO2005075992A1 Mct1 transporter expressed in blood brain barrier cells
08/18/2005WO2005075684A2 Use of organic anion transporter b in screens for candidate substrates for crossing the blood brain barrier
08/18/2005WO2005075681A1 Method of examining sensitivity of cancer cell to anticancer agent
08/18/2005WO2005075663A2 Nanosized composite material containing a biological compound and process for the preparation
08/18/2005WO2005075575A1 Compositions containing cis-isomers of a carotenoid compound and process
08/18/2005WO2005075501A1 Polyoxyalkylene compound and method for making
08/18/2005WO2005075495A1 6-o-substituted ketolide derivatives
08/18/2005WO2005075492A1 Prodrug comprising 5-aminosalicylate glycoside
08/18/2005WO2005075491A1 6r-(3,6-dideoxy-l-arabino-hexopyranosyloxy)heptanoic acid, preparation process for the same and dauer effect thereof
08/18/2005WO2005075484A2 Chemokine ccr5 receptor modulators
08/18/2005WO2005075482A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
08/18/2005WO2005075471A2 Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
08/18/2005WO2005075467A2 Crystalline forms of zolmitriptan
08/18/2005WO2005075460A2 Pyrrolopyrimidine derivatives for treating proliferative diseases
08/18/2005WO2005075449A1 Compounds and methods to increase anti-p-glycoprotein activity of baicalein by alkylation on the a ring
08/18/2005WO2005075447A1 Crystalline polymorphs of a cxc-chemokine receptor ligand
08/18/2005WO2005075439A1 Quinazoline derivatives
08/18/2005WO2005075436A2 Novel inhibitors of glutaminyl cyclase
08/18/2005WO2005075427A2 Montelukast sodium polymorphs
08/18/2005WO2005075424A1 New pyridin-2-one compounds useful as inhibitors of thrombin
08/18/2005WO2005075423A1 Extracts of marasmins androsaceus l.es, piperdinone derivatives and the use as antihypertensive agents
08/18/2005WO2005075421A1 Bicycloester derivative
08/18/2005WO2005075420A2 Pyrrolidine derivatives acting as ccr3-receptor antagonists
08/18/2005WO2005075416A1 Amorphous tamsulosin hydrochloride
08/18/2005WO2005075414A1 Peptidyl arginine deiminase type iv inhibitor
08/18/2005WO2005075410A1 New compounds, methods for their preparation and use thereof
08/18/2005WO2005075385A2 Method for producing dry powders of one or several carotenoids
08/18/2005WO2005075078A2 Method for the production of monodispersed pearl polymers containing acrylic
08/18/2005WO2005075023A1 Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism
08/18/2005WO2005075022A2 Susceptibility gene for myocardial infraction, stroke, and paod; methods of treatment
08/18/2005WO2005074995A2 Combined use of prame inhibitors and hdac inhibitors
08/18/2005WO2005074994A1 Oat3 transporter expressed in blood brain barrier cells
08/18/2005WO2005074992A1 Pharmaceutical form of reduced toxicity for oral administration of indomethacin
08/18/2005WO2005074991A1 Antitumor agent
08/18/2005WO2005074990A2 Methods of preventing and treating sars using low ph respiratory tract compositions
08/18/2005WO2005074989A2 Combination of a dna topoisomerase inhibitor and an iap inhibitor
08/18/2005WO2005074988A1 Nerve cell differentiation inducer
08/18/2005WO2005074987A1 Photodynamic therapy for the treatment of acne
08/18/2005WO2005074985A2 Methods of modulating cd200 and cd200r
08/18/2005WO2005074983A2 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
08/18/2005WO2005074982A2 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
08/18/2005WO2005074965A1 Application of natural and synthetic eugenol and essential oils from cloves, pimentos and cinnamon leaves for the prevention and treatment of animal diseases caused by bacteria, fungi and parasites
08/18/2005WO2005074962A1 Muscular tension-elevating agent
08/18/2005WO2005074961A1 Body fat-controlling agent
08/18/2005WO2005074960A1 Physiologically functional drinks and compositions
08/18/2005WO2005074959A1 Anti-allergy composition and related method
08/18/2005WO2005074958A2 Use of an extract of pueraria tuberosa for the treatment of diabetes type 2
08/18/2005WO2005074955A1 Preparations containing echinacea extracts and thiocyanate
08/18/2005WO2005074949A1 Treatment of ungual and subungual diseases with antimicrobial metal compositions
08/18/2005WO2005074948A1 Solid formulation for dialysis and process for producing the same
08/18/2005WO2005074947A2 Anti-viral pharmaceutical compositions
08/18/2005WO2005074946A1 Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
08/18/2005WO2005074945A2 Ketolide compounds for the treatment of atherosclerosis
08/18/2005WO2005074944A1 Use of sodium neridronate to promote new bone formation
08/18/2005WO2005074943A1 Ed-71 preparation
08/18/2005WO2005074942A1 Slow release steroid composition
08/18/2005WO2005074941A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure
08/18/2005WO2005074940A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators
08/18/2005WO2005074939A1 Combination of cb2 modulators and pde4 inhibitors for use in medicine
08/18/2005WO2005074938A1 Drug for inhibiting vascular intimal hyperplasia
08/18/2005WO2005074937A1 Oral cyclodextrin complexes of anti-tuberculosis drug
08/18/2005WO2005074936A1 Aqueous solution containing pyrazoloacridone derivative
08/18/2005WO2005074935A1 Montelukast free acid polymorphs
08/18/2005WO2005074933A1 Small molecule inhibitors of her2 expression
08/18/2005WO2005074932A1 The use of (s) - pantoprazole magnesium for the treatment of airway disorders
08/18/2005WO2005074931A1 Pharmaceutical combinations comprising (s) -pantoprazole
08/18/2005WO2005074930A1 Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
08/18/2005WO2005074929A2 Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
08/18/2005WO2005074928A1 Remedy for hypertension
08/18/2005WO2005074927A1 Therapeutic combination of amlodipine and benazepril/ benazeprilat for the treatment of hypertension
08/18/2005WO2005074926A1 Organic compounds
08/18/2005WO2005074925A1 Compositions substantially free of galactomannan containing piperacillin and tazobactam
08/18/2005WO2005074924A1 Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases
08/18/2005WO2005074923A1 Methods and compositions
08/18/2005WO2005074922A1 1H-THIENO[2,3-c]PYRAZOLE DERIVATIVES USEFUL AS KINASE INHIBITORS
08/18/2005WO2005074921A1 Treatment of atherosclerosis
1 ... 4572 4573 4574 4575 4576 4577 4578 4579 4580 4581 4582 4583 4584 4585 4586 4587 4588 4589 4590 4591 4592 ... 7860